Vaidya Sane Ayurved Laboratories Secures Indian Patent for Herbal Formulation Method
Vaidya Sane Ayurved Laboratories Limited has been granted an Indian Patent by the Office of the Controller General of Patents, Designs and Trade Marks, Government of India. The patent pertains to an innovative method of preparation of herbal formulation.The grant provides the company with statutory intellectual property protection for the invention. Details regarding the newly granted patent are as follows:
| Particulars | Details |
|---|---|
| Patent Title | Method of Preparation of Herbal Formulation |
| Patent Number | 593487 |
| Patent Application No. | 201921049131 |
| Date of Filing | November 29, 2019 |
| Date of Grant | June 25, 2026 |
| Patentee | Vaidya Sane Ayurved Laboratories Limited |
The patent relates to the innovative preparation method and is valid for a period of 20 years from the date of filing, subject to applicable renewal fees.
The grant of this intellectual property strengthens the company's portfolio in research, innovation, and development of proprietary Ayurvedic formulations. Vaidya Sane Ayurved Laboratories Limited believes that the patented technology will support its long-term business strategy and enhance its competitive positioning within the healthcare and Ayurvedic products segment.
MADHAVBAUG Stock Price Movement
As of 12:34 PM, shares of Vaidya Sane Ayurved Laboratories Limited are edging higher to ₹182.00, gaining 3.76% in live trading. The stock saw brisk movement as 3,600 shares were transacted during the morning session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.